Phase Ii Study Of Pi3k Inhibitor Copanlisib In Cancer Patients With Deleterious Pten Mutations And Retained Pten Protein Expression: Results From The Nci-Match Trial (Eay131) Sub-Protocol Z1h
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要